🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/06/2025 | 79,84 | 80,25 | 78,37 | 78,83 | -1,05% | 2,35% | 13.760.100 |
| 25/06/2025 | 79,64 | 80,12 | 79,16 | 79,67 | -0,81% | 1,21% | 12.753.200 |
| 24/06/2025 | 80,37 | 81,46 | 79,09 | 80,32 | +0,20% | 2,95% | 15.906.400 |
| 23/06/2025 | 79,24 | 80,22 | 78,99 | 80,16 | +1,39% | 1,55% | 18.553.800 |
| 20/06/2025 | 79,25 | 79,92 | 78,60 | 79,06 | -0,29% | 1,67% | 34.052.300 |
| 18/06/2025 | 78,05 | 80,31 | 77,10 | 79,29 | +1,29% | 4,11% | 23.803.400 |
| 17/06/2025 | 80,28 | 80,70 | 78,19 | 78,28 | -3,31% | 3,13% | 14.040.600 |
| 16/06/2025 | 80,88 | 81,35 | 79,71 | 80,96 | -0,92% | 2,03% | 12.569.400 |
| 13/06/2025 | 81,65 | 82,44 | 81,45 | 81,71 | -0,13% | 1,21% | 14.550.500 |
| 12/06/2025 | 80,19 | 82,11 | 80,07 | 81,82 | +1,87% | 2,54% | 13.169.200 |
| 11/06/2025 | 81,35 | 81,68 | 79,98 | 80,32 | -1,27% | 2,09% | 11.803.300 |
| 10/06/2025 | 79,34 | 81,88 | 79,33 | 81,35 | +2,55% | 3,21% | 13.254.100 |
| 09/06/2025 | 79,61 | 80,41 | 78,67 | 79,33 | +0,46% | 2,19% | 18.305.800 |
| 06/06/2025 | 78,30 | 79,49 | 78,21 | 78,97 | +1,74% | 1,63% | 9.863.100 |
| 05/06/2025 | 78,41 | 78,55 | 77,25 | 77,62 | -0,83% | 1,66% | 13.983.700 |
| 04/06/2025 | 77,47 | 79,14 | 77,33 | 78,27 | +1,46% | 2,34% | 13.009.300 |
| 03/06/2025 | 76,00 | 77,19 | 75,44 | 77,14 | +1,17% | 2,30% | 18.139.200 |
| 02/06/2025 | 77,02 | 77,02 | 75,40 | 76,25 | -0,77% | 2,10% | 11.271.800 |
| 30/05/2025 | 76,94 | 77,56 | 75,59 | 76,84 | +0,58% | 2,56% | 20.641.500 |
| 29/05/2025 | 75,69 | 77,00 | 75,69 | 76,40 | +0,30% | 1,73% | 10.785.200 |
| 28/05/2025 | 77,43 | 77,72 | 75,59 | 76,17 | -1,83% | 2,75% | 12.293.200 |
| 27/05/2025 | 78,02 | 78,20 | 77,05 | 77,59 | +0,01% | 1,47% | 11.884.500 |
| 23/05/2025 | 77,55 | 77,90 | 77,08 | 77,58 | -0,33% | 1,06% | 10.902.200 |
| 22/05/2025 | 76,72 | 78,36 | 76,68 | 77,84 | +1,12% | 2,19% | 11.800.000 |
| 21/05/2025 | 77,77 | 78,10 | 76,87 | 76,98 | -1,27% | 1,58% | 11.879.500 |
| 20/05/2025 | 77,55 | 79,18 | 77,42 | 77,97 | +0,96% | 2,27% | 13.262.400 |
| 19/05/2025 | 75,96 | 77,25 | 75,69 | 77,23 | +1,54% | 2,05% | 11.682.600 |
| 16/05/2025 | 74,99 | 76,17 | 74,37 | 76,06 | +1,68% | 2,40% | 15.021.800 |
| 15/05/2025 | 73,77 | 74,81 | 73,31 | 74,80 | +1,81% | 2,03% | 15.274.800 |
| 14/05/2025 | 77,46 | 77,46 | 73,32 | 73,47 | -4,12% | 5,34% | 23.721.800 |